跳至主要内容
临床试验/CTRI/2020/12/029697
CTRI/2020/12/029697尚未招募1 期

A Clinical Study of Virechana and Avalgujadi Lepa along with Asanadi gana Kwatha (Internally) in the Management of Shwitra w.s.r to Vitiligo

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年12月18日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in subjective and objective parameters

研究概览

简要总结

Vitiligo is a common skin disorder that is thought to be mediated by immunological mechanisms .In modern science , main stream of treatment for vitiligo is PUVA (Psoralen + Ultraviolet A), along with corticosteroid therapy ,etc ,which has several adverse effects , also carries health risks . Therefore , its high time to provide the patients of vitiligo with less complicating , fruitful management through ayurveda . This study is open labelled parallel group trial to prove the efficacy of virechana and avalgujadi lepa along with asanadi gana kwatha (internally) in the management of shwitra w.s.r to vitiligo  . In one group , 15 patients will be administered  virechana karma with aragwadha phala majja kashaya and internal administration of asanadi gana kwatha (15ml before food twice a day for 15 days ) . In another group, 15 patients will be administered with avalgujadi lepa and internal administration of asanadi gana kwatha  (15 ml before food twice a day for 15 days )

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients diagnosed with uncomplicated vitiligo , either segmental or generalized 2.Patients indicated for virechana karma.

排除标准

  • Vitiligo associated with other systemic diseases like tuberculosis , rheumatoid arthritis ,Systemic lupus erythematous, anaemia,hypothyroidism etc
  • Patches due to burns , chemical explosion etc
  • Patients of albinism of skin.

结局指标

主要结局

Improvement in subjective and objective parameters

时间窗: 45 days

次要结局

  • To find out the comparative efficacy of the treatment in both the groups(45 days)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验